Fibroblast growth factor 23

1
Assets
1
Companies

Target Biology

Competitive Landscape

Asset Company Stage Mechanism Lead Indication Ownership
TransCon_FGF-23_degrader ASND Preclinical TransCon protein degrader

Companies

ASND 1 asset(s)
Preclinical
← Back to All Targets